TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 50 filers reported holding TALARIS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,703 | +16793.8% | 962 | -88.9% | 0.00% | -100.0% |
| Q1 2023 | $16 | +77.8% | 8,666 | -4.1% | 0.00% | – |
| Q4 2022 | $9 | -100.0% | 9,034 | +4.6% | 0.00% | – |
| Q3 2022 | $23,000 | +53.3% | 8,637 | +156.4% | 0.00% | – |
| Q2 2022 | $15,000 | -81.0% | 3,369 | -58.0% | 0.00% | -100.0% |
| Q1 2022 | $79,000 | +618.2% | 8,013 | +1031.8% | 0.00% | – |
| Q4 2021 | $11,000 | +10.0% | 708 | -9.8% | 0.00% | – |
| Q3 2021 | $10,000 | +900.0% | 785 | +1166.1% | 0.00% | – |
| Q2 2021 | $1,000 | – | 62 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $5,513,299 | 6.67% |
| BML Capital Management, LLC | 1,929,484 | $3,627,430 | 3.14% |
| Western Standard LLC | 586,481 | $1,102,584 | 1.12% |
| Cormorant Asset Management, LP | 900,649 | $1,693 | 0.11% |
| Artal Group S.A. | 914,262 | $1,719 | 0.10% |
| Values First Advisors, Inc. | 52,896 | $99,445 | 0.06% |
| Blackstone Inc. | 8,089,315 | $15,207,912 | 0.06% |
| Eventide Asset Management | 1,561,092 | $2,934,853 | 0.05% |
| Marquette Asset Management, LLC | 101,375 | $190,585 | 0.05% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $6,184,480 | 0.03% |